本文报告了作者等用敷贴器放射治疗102眼视网膜母细胞瘤17年的经验。(一)病例与方法:自1974年2月～1991年6月,17年间在Wills眼科医院眼部肿瘤科全部诊断为视网膜母细胞瘤患者均包括在本研究中。方法是选出应用敷贴器放射治疗患者进行研究,根据肿瘤大小、玻璃体播种状况及肿瘤部位,选择同位素,以获得最佳剂量分布。在初期主要用钴60放射性同位素,但在近来主要用碘125,因为后者有照射安全及可选择适合患 This article reports the authors’ experience of radiotherapy for 102 eyes of retinoblastoma with an applicator for 17 years. (A) cases and methods: from February 1974 to June 1991, 17 years in the Wills Eye Hospital, Department of Ophthalmology, all of the patients diagnosed as retinoblastoma were included in this study. The method is to select the application of radiation therapy device for patients to study, according to tumor size, vitreous seeding status and tumor site, select the isotope to obtain the best dose distribution. In the early primary cobalt 60 radioisotopes, but in the recent main use of iodine 125, because the latter is safe irradiation and can choose to fit